Top Trends Transforming the Coronary Angiography Devices Market Landscape in 2025: Advancements in Coronary Angiography

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Coronary Angiography Devices Industry Market Size Be by 2025?
The market for coronary angiography devices has seen significant growth recently. It is projected to expand from $9.43 billion in 2024 to $10.1 billion in 2025, with a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be ascribed to factors such as the rising prevalence of cardiovascular diseases, an increasing aging population, growing demand for interventional cardiology, a preference for minimally invasive procedures, and the improvement of healthcare infrastructure.

What's the Long-Term Growth Forecast for the Coronary Angiography Devices Market Size Through 2029?
Expectations are high for robust growth in the coronary angiography devices market in the coming years. The market size is projected to reach $13.13 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.8%. The predicted growth over the forecast period can be ascribed to an increased awareness about cardiac health, a rising preference for telemedicine, higher health care expenditure, prioritization of patient-centered care, and a growing incidence of diabetes. The period is also likely to see significant trends such as technological progress, improvements in hybrid angiography systems, inventive catheter design enhancements, developments in compact design, and advancements in imaging software.

View the full report here:
https://www.thebusinessresearchcompany.com/report/coronary-angiography-devices-global-market-report

What Are the Key Growth Drivers Fueling the Coronary Angiography Devices Market Expansion?
The rise in vascular heart disease cases is projected to fuel the expansion of the coronary angiography devices market. Vascular heart disorders consist of conditions that impact the blood vessels either within the heart or those responsible for its supply. Factors such as lifestyle modifications, including diet and physical exertion, the aging populace, and growing instances of health issues like diabetes and hypertension, are contributing to the heightened prevalence of vascular heart diseases. Coronary angiography devices offer a significant contribution in the diagnosis and evaluation of these heart conditions by giving a comprehensive view of coronary arteries. This enables accurate identification of blockages or narrowing, enabling better treatment planning. For instance, the Centers for Disease Control and Prevention reported in October 2024 that heart disease continues to be the primary cause of death in most demographic groups in the United States. In 2022, heart disease was responsible for 702,880 deaths, accounting for one in every five deaths. Each year, approximately 805,000 individuals suffer a heart attack, with around 605,000 experiencing it for the first time and 200,000 having a prior history of heart attacks. Furthermore, every 33 seconds, someone loses their life to cardiovascular disease. Consequently, the escalating incidence of vascular heart diseases is triggering the growth of the coronary angiography devices market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18800&type=smp

What Are the Key Trends Driving Coronary Angiography Devices Market Growth?
Key firms in the coronary angiography devices sector are introducing cutting-edge products that incorporate AI-powered imaging technology to bolster the precision and efficacy of coronary angiography operations. These AI-propelled imaging advancements utilize artificial intelligence to boost the accuracy and swiftness of angiography by facilitating image analysis automation, leading to an enhancement of diagnostic correctness and trimmed procedure timings. For illustration, Shimadzu Corporation, a Japan-originated medical equipment manufacturer, released an upgraded version of the firm's Trinias angiography system in June 2022. The new system uses AI deep learning technology to improve image processing and notably decrease X-ray doses by over 40%. The system provides a customizable workspace packed with nearly 100 capabilities, offering optimized setups that are specific to individual procedures and team requirements. In addition, the SCORE Link service, which is subscription-based, provides regular software updates thus promoting operational proficiency and sustainability in clinical contexts.

How Is the Coronary Angiography Devices Market Segmented?
The coronary angiography devices market covered in this report is segmented -

1) By Product Type: Angiography Systems, Angiography Catheters, Angiography Contrast Media, Vascular Closure Devices (VCDs), Angiography Balloons, Angiography Guidewires, Angiography Accessories
2) By Technology: X-Ray Angiography, Computed Tomography Angiography (CTA), Magnetic Resonance Angiography, Other Technologies
3) By Indication: Coronary Artery Disease, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure, Other Indications
4) By Application: Diagnostics, Therapeutics
5) By End-User: Hospital And Clinics, Diagnostic And Imaging Centers, Research Institutes

Subsegments:
1) By Angiography Systems: X-Ray Angiography Systems, 3D Or 4D Angiography Systems, Digital Subtraction Angiography (DSA) Systems
2) By Angiography Catheters: Diagnostic Catheters, Therapeutic Catheters, Over-The-Wire (OTW) Catheters, Rapid Exchange (RX) Catheters
3) By Angiography Contrast Media: Iodinated Contrast Media, Non-Iodinated Contrast Media
4) By Vascular Closure Devices (VCDs): Mechanical VCDs, Passive Hemostasis VCDs, Active Hemostasis VCDs
5) By Angiography Balloons: High-Pressure Balloons, Low-Pressure Balloons, Drug-Eluting Balloons
6) By Angiography Guidewires: Standard Guidewires, Supportive Guidewires, Steerable Guidewires
7) By Angiography Accessories: Introducer Sheaths, Inflation Devices, Syringes And Needles, Guidewire Support Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18800&type=smp

Which Companies Are Leading the Charge in Coronary Angiography Devices Market Innovation?
Major companies operating in the coronary angiography devices market are Cardinal Health Inc., Hitachi Ltd., Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Terumo Corporation, Edwards Lifesciences Corporation, Nipro Corporation, Shimadzu Corporation, Cook Group Incorporated, ICU Medical Inc., Biotronik SE Co. KG, Merit Medical Systems Inc., Cordis Corporation, Guerbet N.V., AngioDynamics Inc., Canon Medical Systems Corporation, Acist Medical Systems, Medinol Ltd., Alvimedica

Which Regions Are Leading the Global Coronary Angiography Devices Market in Revenue?
North America was the largest region in the coronary angiography devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary angiography devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18800

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.